Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fanyin Meng

Showing results (81-90 of 148) with videos related to

Pageof 15
Sort By:
Journal of Cellular and Molecular Medicine|December 10, 2015
Role of stem cells during diabetic liver injuryYing Wan, Jessica Garner, Nan Wu, et al.
Cells|February 20, 2020
Neuroendocrine Changes in Cholangiocarcinoma GrowthKeisaku Sato, Heather Francis, Tianhao Zhou, et al.
The American Journal of Pathology|February 28, 2024
The Role of miRNA and Long Noncoding RNA in Cholestatic Liver DiseasesYudian Zhang, Ying Liu, Wen Huo, et al.
Cancer Letters|November 30, 2016
Inhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma growthChad Hall, Laurent Ehrlich, Julie Venter, et al.
Journal of Hepatology|June 28, 2011
Regulation of placenta growth factor by microRNA-125b in hepatocellular cancerGianfranco Alpini, Shannon S Glaser, Jing-Ping Zhang, et al.
Hepatology (Baltimore, Md.)|June 29, 2016
Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2(-/-) miceHannah Jones, Laura Hargrove, Lindsey Kennedy, et al.
Journal of Hepatology|March 1, 2016
miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growthYuyan Han, Fanyin Meng, Julie Venter, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 29, 2017
Melatonin inhibits hypothalamic gonadotropin-releasing hormone release and reduces biliary hyperplasia and fibrosis in cholestatic ratsMatthew McMillin, Sharon DeMorrow, Shannon Glaser, et al.
Hepatology (Baltimore, Md.)|March 31, 2018
Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2<sup>-/-</sup> mice and human cholangiocarcinoma tumorigenesisLindsey Kennedy, Laura Hargrove, Jennifer Demieville, et al.
Molecular Cancer Research : MCR|October 15, 2009
H3 histamine receptor-mediated activation of protein kinase Calpha inhibits the growth of cholangiocarcinoma in vitro and in vivoHeather Francis, Paolo Onori, Eugenio Gaudio, et al.
Pageof 15

Showing results (81-90 of 148) with videos related to

Sort By:
Pageof 15
Journal of Cellular and Molecular Medicine|December 10, 2015
Role of stem cells during diabetic liver injuryYing Wan, Jessica Garner, Nan Wu, et al.
Cells|February 20, 2020
Neuroendocrine Changes in Cholangiocarcinoma GrowthKeisaku Sato, Heather Francis, Tianhao Zhou, et al.
The American Journal of Pathology|February 28, 2024
The Role of miRNA and Long Noncoding RNA in Cholestatic Liver DiseasesYudian Zhang, Ying Liu, Wen Huo, et al.
Cancer Letters|November 30, 2016
Inhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma growthChad Hall, Laurent Ehrlich, Julie Venter, et al.
Journal of Hepatology|June 28, 2011
Regulation of placenta growth factor by microRNA-125b in hepatocellular cancerGianfranco Alpini, Shannon S Glaser, Jing-Ping Zhang, et al.
Hepatology (Baltimore, Md.)|June 29, 2016
Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2(-/-) miceHannah Jones, Laura Hargrove, Lindsey Kennedy, et al.
Journal of Hepatology|March 1, 2016
miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growthYuyan Han, Fanyin Meng, Julie Venter, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 29, 2017
Melatonin inhibits hypothalamic gonadotropin-releasing hormone release and reduces biliary hyperplasia and fibrosis in cholestatic ratsMatthew McMillin, Sharon DeMorrow, Shannon Glaser, et al.
Hepatology (Baltimore, Md.)|March 31, 2018
Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2<sup>-/-</sup> mice and human cholangiocarcinoma tumorigenesisLindsey Kennedy, Laura Hargrove, Jennifer Demieville, et al.
Molecular Cancer Research : MCR|October 15, 2009
H3 histamine receptor-mediated activation of protein kinase Calpha inhibits the growth of cholangiocarcinoma in vitro and in vivoHeather Francis, Paolo Onori, Eugenio Gaudio, et al.
Pageof 15